Oversubscribed SPP Raises $2.0M
Filed with ASX · · 2 pages · English
Summary by 6ix AI
EMvision Medical Devices Ltd. has announced the successful completion of its oversubscribed Share Purchase Plan, raising significant funds. This funding, combined with a recent placement, strengthens the company's financial position to advance key projects, including clinical trials and regulatory preparations. The oversubscription led to a scaling back of applications to ensure equitable distribution among shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Oversubscribed SPP To Close Early
- $3m CRC-P Grant Executed & First Payment Received
- SPP Offer Document & Option Prospectus
- Pre-Hospital MSU Study Commences with First Responder Device
- Firm Commitments for $12.0M Placement & Launch of SPP
Later from EMvision Medical Devices
- First Responder Aeromedical Study Commences
- Strong emu Clinical Trial & Program Progress
- Quarterly Activities/Appendix 4C Cash Flow Report
- Half Yearly Report and Accounts
- EMVision Medical Devices to Present at Australia Investor Day February 26th
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices